Prevention with Sublay Mesh of Trocar Site Hernia (PRESUME): Study Protocol for a Multicenter Randomized Controlled Trial
Journal of Abdominal Wall Surgery · 27.03.2026 · 5
DOI: 10.3389/jaws.2026.16067 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Abdominal Wall Surgery, online erschienen am 27.03.2026. Verfasst von Emma Sánchez-Sáez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Parc Sanitari Sant Joan de Déu, España, Spain. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Trocar Site Incisional Hernia (TSIH) is the most common postoperative complication after laparoscopic surgery, with incidences exceeding 30% in high-risk patients. Despite advances in minimally invasive approaches, optimal preventive strategies remain uncertain, and evidence comparing closure or reinforcement techniques is limited. Prophylactic mesh use shows benefits in open surgery, but its role in laparoscopy requires further clarification.
Objective
The PRESUME study evaluates whether prophylactic sublay mesh placement at the umbilical trocar site reduces TSIH incidence in patients undergoing laparoscopic cholecystectomy who present at least one established risk factor. Secondary objectives include assessing mesh-related complications and short- and long-term postoperative outcomes.
Methods
This prospective, multicentre, randomised controlled trial provides Level I evidence. Eligible participants are adults scheduled for laparoscopic cholecystectomy with diabetes mellitus, BMI ≥30 kg/m 2 , age ≥65 years, or requiring umbilical incision enlargement. Patients will be randomised 1:1 to standard aponeurotic closure or intraperitoneal sublay mesh reinforcement (Ventralex™ ST). Follow-up visits are scheduled at 30 days, 6 months, 1 year—with ultrasound—and 2 years. The principal investigator will remain blinded during follow-up. The primary endpoint is TSIH incidence; secondary outcomes include surgical site events, postoperative pain, readmissions, and time to return to daily activities. Based on expected TSIH reduction from 35% to 10%, 42 patients per arm are required.
Discussion
TSIH remains a significant postoperative issue with limited preventive evidence in laparoscopy. By assessing the efficacy and safety of prophylactic sublay mesh reinforcement, the PRESUME trial may support future recommendations and improve outcomes in high-risk patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Parc Sanitari Sant Joan de Déu, España, Spain.
- Universitat Autonoma de Barcelona, Barcelona, Spain.
- Hospital Universitari Vall d'Hebron, Barcelona, Spain.
- Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Zitieren
APA
Sánchez-Sáez, E., Sebastian-Valverde, E., Vilallonga Puy, R., & Ciscar Bellés, A. (2026). Prevention with Sublay Mesh of Trocar Site Hernia (PRESUME): Study Protocol for a Multicenter Randomized Controlled Trial. Journal of Abdominal Wall Surgery, 5. https://doi.org/10.3389/jaws.2026.16067
Vancouver
Sánchez-Sáez E, Sebastian-Valverde E, Vilallonga Puy R, Ciscar Bellés A. Prevention with Sublay Mesh of Trocar Site Hernia (PRESUME): Study Protocol for a Multicenter Randomized Controlled Trial. Journal of Abdominal Wall Surgery. 2026;5. doi:10.3389/jaws.2026.16067
BibTeX
@article{SnchezSez2026,
author = {Sánchez-Sáez, Emma and Sebastian-Valverde, Enric and Vilallonga Puy, Ramon and Ciscar Bellés, Ana},
title = {Prevention with Sublay Mesh of Trocar Site Hernia (PRESUME): Study Protocol for a Multicenter Randomized Controlled Trial},
journal = {Journal of Abdominal Wall Surgery},
year = {2026},
volume = {5},
doi = {10.3389/jaws.2026.16067}
}
EUVIMED